INDIAN DRUGS & PHARMACEUTICALS LIMITED
(A Government of India Undertaking)
CIN No. U24231HR1961GOI003418

Tel No.:-0124-2456026, Fax:-0124-4303744

NOTICE INVITING TENDER (NIT)

Tender Enquiry No. IDP/CO/FINANCE/2021-22/01 Dated: 06.04.2021

Indian Drugs & Pharmaceuticals Limited is looking for a dynamic CA Firm who can take up the assignment
of preparations & finalizations of Annual Accounts of Corporate Office and consolidation with Regions &
Plants Balance Sheet for the Financial Year 2019-20 and 2020-21 (ongoing basis) immediately for the
purpose of review by our Statutory Auditors u/s 619 (2) of the Companies Act.

Interested parties, fulfilling eligibility criteria are requested to submit duly filled tender documents in two bid
system i.e. Technical Bid and Financial bid specifying clearly on the Covers. Bids shall be submitted on or
before 1400 Hrs on 27.04.2021 and Technical Bid will be opened on the same date at 1430 Hrs. Date and
time for opening of Financial Bid will be informed to bidders (qualifying in technical evaluation) later. The
detail of tender document can also be downloaded from our website www.idplindia.in

SCOPE OF WORK FOR THE YEAR 2019-20 & 2020-21:

The scope of work extends up to interacting with the respective Internal Auditors, Statutory Auditors/Branch
Auditors and Auditors of CAG till finalization of the accounts in all respects.

The following table indicates the location details of the Company:

LOCATION ADDRESS
Registered Office & Office Address Corporate Office, IDPL Complex, Dundahera, Haryana

3 (Three) Factories/Units Hyderabad Plant, Rishikesh Plant, Gurgaon Plant
5 (Five) Zones Delhi, Mumbai, Kolkata, Lucknow, Hyderabad

Purview of Statutory Auditors includes audit of Accounts of Corporate Office & Marketing Division (H.O)
and all India consolidated Accounts.

While the purview of Branch Auditors/Unit Auditor (5) extends to audit of Delhi, Lucknow, Hyderabad,
Mumbai & Kolkata RSO & 3 Plants as above.

Business Volume: Company’s turnover for the Financial Year 2019-20 and 2020-21 are 11 Cr. and 14.85
lacs respectively as the company is in the process of closure in view of decision of the Union Cabinet taken
its meeting held on 28.12.2016.

It is imperative that the Annual Accounts for the financial year 2019-20 and 2020-21 have to be put before
the Statutory Auditors suitably. Time being essence of such an arrangement, it is expected that firm will have
to mobilize and depute sufficient teams comprising of competent and qualified personnel for expeditious
finalizations of Annual Accounts of 2019-20 and 2020-21. Any Inordinate delay on the part of the firm (like
not submitting consolidated accounts based on Branch/Units provisional & audited accounts within 15-20
days) will attract suitable penalty as may be decided by IDPL management/CMD based on actual number of
days delayed and the circumstances of such delays.
The assignment includes:-
1. Data entry of Cash, Journal, Bank and all other financial transactions of Head/Corporate Office for
the years 2019-20 and 2020-21 on Tally ERP package (original version)
2. Reconciliation of all Bank Accounts

3. Reconciliation and preparation of all schedules like T.A. Advances, Staff Advances and Medical
Advances etc.

4. Reconciliation of Inter unit accounts with Regions & Plants.

5. Drawing of Balance Sheet of Corporate Office (with all schedules).

6. Consolidation of Balance Sheet of five Regions.

7. Merger of Balance Sheet of Corporate Office with five regions and three plants.

8. Drawing final accounts for the year 2019-20 and 2020-21 in MS excel format.

9. Assistance in Statutory, CAG & MAB Audits.

10. Preparation of Quarterly Profit & Loss A/c, Balance Sheet with schedules (consolidated) for FY
2019-20 and 2020-21 (to be prepared by 00-00-0000 and thereafter by 15th of the following month)

11. Certification/Verification of various statement (requiring CA certification) required by various
authorities.

12. Vetting of various write off/provisions proposals of Corporate Office & Marketing Division.

13. Quarterly compliances of TDS matters, checking of accuracy of deductions and timely deposit
thereof to be reported.

14. Monthly compliance of GST, checking of calculations and reporting the deposit if same on due
dates.

ELIGIBLITY CRITERIA/TECHNICAL DETAILS:-

1. The firm should have ten year of standing as on the date of submission of applications.

2. Should have minimum two full time partners who are with the firm for at least five years.

3. The Firm should have been empanelled with CAG and should have completed at least one such
Audit allotted by CAG.

4. Should have experience of handling Accounting Assignments or similar type of assignment of large
sized Pharmaceuticals Company.

5. Firm must be registered with GST Department

6. Should not have carried out any Statutory Audit assignment for IDPL or any of its units within the
last one year before the date of submission of application.

7. PSU Experience of 7 years in Internal Audit, Statutory or Accounts preparation.

8. Should not have been debarred, blacklisted or disqualified by any regulatory body or Govt. entity for
corrupt or fraudulent practices.

Chief Financial Officer I/c
IDPL
TERMS AND CONDITIONS:-

1. Preparation of accounts work and finalization will require to be carried out in Corporate Office
premises at Gurgaon. While suitable office space shall be provided by the Company. CA Firm so
selected will have to install its own Computers and at least depute 2-3 assistants having full
knowledge of accounts preparation and finalization on regular basis. The firm will have to designate
one partner for supervising the work and its timely progress. Designated partner will make himself
available for discussions at Corporate Office - Gurgaon whenever required.

2. Further, details of scope of work, if required, will be available from Corporate Office by contacting
CFO /DFM- IDPL from 11.00 A.M to 5.00 P.M.

3. Proposals are invited from Chartered Accountants firms who meet the above eligibility criteria can
apply within 21 (twenty one) days of issue of the advertisement.

Application need to be submitted in two separate sealed covers. One of the cover should be clearly
marked boldly “Technical Bid” and should contain details of the eligibility criteria/technical details
with supporting Xerox Copy of documents in support of Item No. 1 to 7 & signed undertaking in
support of Item No 8 of the eligibility criteria/technical details. The second cover boldly marked as
“Price Bid” (Annexure-I) should include the Quotation for the Professional Fees for the year 2019-20
and 2020-21 separately. Tender Number and date of opening should also be mentioned on both the
envelopes. Both the covers should be addressed to CFO I/C – IDPL and should be received by 2.00
P.M. on 27.04.2021 at the following address:

“Indian Drugs & Pharmaceuticals Limited
Corporate Office, IDPL Complex,
Old Delhi – Gurgaon Road,
Dundahera, Gurgaon – 122016 (Haryana)”

4. Applications will be opened in the presence of CA Firm who may like to be present at 2.30 P.M. on
the same day. The Financial Bid cover will be opened only for those firms which qualify the
technical details.

5. Professional Fees will be inclusive of all expenses but exclusive of GST etc. and no separate
conveyance or other expenses are payable.

However, if partner of the firm or assistant is required to visit outstation units for work related to the
assignments suitable travelling and other expenses will be reimbursed.

6. Company reserves the right to accept or reject any or all the proposals. Decisions of IDPL would be
final & binding.

7. Exit Clause: The engagement may be terminated by either side at the end of any financial year by
giving 1 months’ notice in writing.

8. Payment Terms:-
a) 15% on data entry, bank reconciliation of corporate office accounts.

b) 50% after drawing of balance sheet of corporate office, marketing division & its
consolidation along with schedules.
c) 20% after completion of Statutory Audit (including replies
d) 15% after completion of MAB/CAG Audit and reply of their comments.

Validity Period: Last date for submission of Technical & Financial bids is 27.04.2021 However; the
company may seek additional information or clarification from any applicant after the last date which need to
be submitted in 3 days’ time.
Annexure-I

PRICE BID

Name of Work Professional GST Total
Fees @....... Amount
1. Data entry of Cash, Journal, Bank and all other financial
transactions of Head/Corporate Office for the years 2019-20 and (Amount in (Rs.)
2020-21 on Tally ERP package (original version) Rs.)

2. Reconciliation of all Bank Accounts
3. Reconciliation and preparation of all schedules like T.A.

Advances, Staff Advances and Medical Advances etc.
4. Reconciliation of Inter unit accounts with Regions & Plants.
5. Drawing of Balance Sheet of Corporate Office (with all

schedules).
6. Consolidation of Balance Sheet of five Regions.
7. Merger of Balance Sheet of Corporate Office with five regions

and three plants.
8. Drawing final accounts for the year 2019-20 and 2020-21 in MS

excel format.
9. Assistance in Statutory, CAG & MAB Audits.
10. Preparation of Quarterly Profit & Loss A/c, Balance Sheet with

schedules (consolidated) for FY 2019-20 and 2020-21 (to be
prepared by 00-00-0000 and thereafter by 15th of the following
month)
11. Certification/Verification of various statement (requiring CA
certification) required by various authorities.
12. Vetting of various write off/provisions proposals of Corporate
Office & Marketing Division.
13. Quarterly compliances of TDS matters, checking of accuracy of
deductions and timely deposit thereof to be reported.
14. Monthly compliance of GST, checking of calculations and
reporting the deposit if same on due dates.

(Total Amount in Word……………………………………………………………………………...)
Note:-

1. The Fee quoted should be all inclusive. No further charge /fee /expenses (including travelling and
stay etc.) will be paid by IDPL.

2. Amount will be written in both figures and words. If there is any difference between figures and
words, the words will prevail.

3. Quoted Rate should be only in sealed envelope. Price Bid in open condition will result in
disqualification of the bid.

Signature with Seal / Stamp of the CA Firm.